Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity Systems Joins Biomarkers Consortium

NEW YORK (GenomeWeb News) — Ingenuity Systems said yesterday that it has joined the Biomarkers Consortium, a public-private endeavor aimed at developing, discovering, and qualifying new biomarkers for drug development, preventive medicine, and medical diagnostics.
The consortium was founded by the Foundation for the National Institutes of Health, the National Institutes of Health, the US Food and Drug Administration, the Centers for Medicare and Medicaid Services, and the Pharmaceutical Research and Manufacturers of America. It now comprises around 30 partners, including companies, patient advocacy organizations, government groups, and non-profits.
The consortium this summer launched a website that offers more information, accepts proposals for projects, and offers information on funding opportunities.
Ingenuity makes pathway analysis and knowledge-base software that helps researchers explore, analyze, and interpret scientific literature and data.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.